BEPREVE
BEPREVE
Approved
DIN Number
02456532
Drug Class
Human
Market Date
Mar 23, 2017
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02456532
AIG Number0158330001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01 OPHTHALMOLOGICALS
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:02.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BEPOTASTINE BESILATEActive
Strength: 1.5 % / W/V
Monograph: BEPOTASTINE BESILATE